Health, Wellness, and BeautyProduct Selection & Quality

Heparin vials from a specific supplier (Fresenius Kabi) appear to be ineffective, requiring abnormally high doses to achieve therapeutic ACT levels during PCI procedures, causing frustration among cli

Opp. Score

Reports

Severity

4High

Trend

stable

First Seen

May 14, 2026

Generate a build spec

User stories, data model, API surface and a two-to-four week MVP cut — grounded in what these 1 reports actually said. Markdown you can paste into a coding agent.

Solutions (0)

Problem Reports (1)

PharmAlert Drug Quality Tracker

Heparin vials from a specific supplier (Fresenius Kabi) appear to be ineffective, requiring abnormally high doses to achieve therapeutic ACT levels during PCI procedures, causing frustration among clinical staff and reluctance from management to switch suppliers.

Health, Wellness, and Beauty4HighNurse or Clinician

Want to go deeper?

Sign up to save ideas, run AI analysis, and track opportunities in your personal workspace. Founding members get full access.

Join Beta

Discussion (0)

No comments yet